Han Xu

7PUBLICATIONS
45CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)Medical devicesGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
Acquired Resistance to the PRMT5 Inhibitor Confers Collateral Sensitivity to MEK Inhibition in MTAP-Null Non-Small Cell Lung Cancer.

|Mar 14, 2026
A functional map of m6A sites in cancer.

Yalong Wang, Han Xu

|Jul 02, 2025
Pol θ-mediated end-joining uses microhomologies containing mismatches.

Yuzhen Li, Ngoc K Dang, Wei He

|Nov 06, 2023
CRISPR-Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading frames.

Caishang Zheng, Yanjun Wei, Peng Zhang

|Sep 02, 2023
TAZ2 truncation confers overactivation of p300 and cellular vulnerability to HDAC inhibition.

Longxia Xu, Hongwen Xuan, Wei He

|Aug 04, 2023
Multiomics analyses reveal DARS1-AS1/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance.

Caishang Zheng, Yanjun Wei, Qiang Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Yiwen Chen

2 joint publications

Yanjun Wei

2 joint publications

Wei He

2 joint publications

Wenyi Wang